Augusta Anyama
Psychiatric/Mental Health · Lafayette, LANPI 1972126001
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.6% of the total across 63 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 20.0% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,319, 2.1 times the $618 reported in 2021.
Across 63 payments — averaging $56.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$706
- Teva Pharmaceuticals USA, Inc.$509
- AbbVie$423
- Axsome Therapeutics, Inc.$244
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$209
- Neuronetics, Inc.$177
- plus $1K from 16 others
What the payments were for
- Food & beverage$3,41197%
- Education$1193%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 14 | $706 |
| Teva Pharmaceuticals USA, Inc. | 14 | $509 |
| AbbVie | 5 | $423 |
| Axsome Therapeutics, Inc. | 2 | $244 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 6 | $209 |
| Neuronetics, Inc. | 1 | $177 |
| E.r. Squibb & Sons, L.L.C. | 3 | $150 |
| Abbott | 1 | $146 |
| Neurocrine Biosciences, Inc. | 2 | $129 |
| Vanda Pharmaceuticals Inc. | 1 | $125 |
| Tris Pharma Inc | 1 | $124 |
| Avanir Pharmaceuticals, Inc. | 1 | $122 |
| Supernus Pharmaceuticals, Inc. | 2 | $118 |
| Boehringer Ingelheim | 1 | $99 |
| Alkermes, Inc. | 1 | $86 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $51 |
| Indivior Inc. | 2 | $26 |
| Lundbeck LLC | 1 | $21 |
| Orexo US, Inc. | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Luye Pharma (USA) Ltd. | 1 | $15 |
| Ironshore Pharmaceuticals Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INVEGA SUSTENNA$256
- Auvelity$244
- VRAYLAR$225
- NEUROSTAR TMS THERAPY SYSTEM$177
- INVEGA$150
- FreeStyle Libre$146
- INVEGA TRINZA$131
- Fanapt$125
- Quillichew ER$124
- Quillivant$124
- Dyanavel XR$124
- CAPLYTA$122
- COBENFY$122
- NUEDEXTA$122
- UZEDY$110
- QELBREE$102
How this compares
$3,531 in reported general payments places this provider in the 75th percentile of 615 psychiatric/mental health providers in Louisiana.
Other psychiatric/mental health in Lafayette
- Melissa GuilbeauLafayette$122K
- Bryant DronetteLafayette$17K
- Cinderella BroussardLafayette$14K
- Lore Lyndsey MoranLafayette$12K
- Danielle ThreattsLafayette$11K
- Seth WoodruffLafayette$10K
- Latonya WoodsLafayette$10K
- Laura KightLafayette$9K
- Amy LacoutureBaton Rouge$663K
- Amanda EymardHouma$617K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.